Editorial comment: Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma. - Suppr | 超能文献

Editorial comment: Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.

作者信息

Fournier Laure

出版信息

BJU Int. 2012 Dec;110(11):1753-4. doi: 10.1111/j.1464-410X.2012.11525.x. Epub 2012 Oct 26.

DOI:10.1111/j.1464-410X.2012.11525.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Editorial comment: Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.

BJU Int. 2012 Dec;110(11):1753-4. doi: 10.1111/j.1464-410X.2012.11525.x. Epub 2012 Oct 26.

2

Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.肿瘤负担是转移性肾细胞癌的一个独立预后因素。

BJU Int. 2012 Dec;110(11):1747-53. doi: 10.1111/j.1464-410X.2012.11518.x. Epub 2012 Oct 26.

3

Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.关于在单一欧洲中心应用常规病理学对透明细胞肾细胞癌的梅奥诊所分期、大小、分级和坏死（SSIGN）评分进行外部验证的编辑评论

Eur Urol. 2010 Jan;57(1):110-1. doi: 10.1016/j.eururo.2008.11.035. Epub 2008 Nov 28.

4

Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.关于在单一欧洲中心应用常规病理学对透明细胞肾细胞癌的梅奥诊所分期、大小、分级及坏死（SSIGN）评分进行外部验证的编辑评论

Eur Urol. 2010 Jan;57(1):109-10. doi: 10.1016/j.eururo.2008.11.034. Epub 2008 Nov 28.

5

Clinically localized renal cell carcinoma: which is the best treatment strategy?临床局限性肾细胞癌：最佳治疗策略是什么？

Clin Genitourin Cancer. 2014 Apr;12(2):e61. doi: 10.1016/j.clgc.2013.03.001. Epub 2013 Nov 12.

6

Editorial Comment to p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.对p21激活激酶1的编辑评论可预测非转移性透明细胞肾细胞癌患者的复发和生存情况。

Int J Urol. 2015 May;22(5):453-4. doi: 10.1111/iju.12732. Epub 2015 Feb 24.

7

Editorial comment to RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass.关于“RENAL肾计量评分是肾肿物年生长率的预测因素”的编辑评论

Int J Urol. 2014 Jun;21(6):553. doi: 10.1111/iju.12394. Epub 2014 Jan 9.

8

Editorial comment on: Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma.关于“包膜侵犯对局限性透明细胞肾细胞癌的预后价值”的社论评论

Eur Urol. 2009 Dec;56(6):1012. doi: 10.1016/j.eururo.2008.11.032. Epub 2008 Nov 28.

9

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.肾周脂肪浸润和肿瘤大小在肾细胞癌中的预后意义

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

10

Editorial Comment.编者按

Urology. 2016 Apr;90:124. doi: 10.1016/j.urology.2015.10.052.

引用本文的文献

1

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma.转移性肿瘤负担和部位作为转移性肾细胞癌患者一线舒尼替尼治疗疗效的预测指标。

Sci Rep. 2019 May 23;9(1):7754. doi: 10.1038/s41598-019-44226-y.